arrow
H

H. Keipp Talbot

Vanderbilt University Medical Center
H指数:86
被引数:3.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Influenza mitigation recommendations, symptoms, and viral RNA shedding durations—2023-2024 and 2024-2025 seasons

流感缓解建议、症状及病毒RNA排出持续时间——2023-2024和2024-2025流行季

2026-09-100
PRE
Trends in Mortality and the Effects of the Coronavirus Disease 2019 Pandemic on Mortality Among Adult Patients With Staphylococcus aureus Bacteremia, 20 US Counties, 2005–2022

金黄色葡萄球菌败血症成人患者死亡趋势及2019冠状病毒病大流行对死亡的影响:美国20个县,2005–2022年

2026-08-210
OAAI
Influenza Vaccination and Symptom Burden in Ambulatory Patients with Confirmed Influenza: Evidence from Case-ascertained Household Transmission Studies

流感疫苗接种与确诊流感门诊患者的症状负担:来自病例确认家庭传播研究的证据

2026-08-130
OAAI
Prevalence and outcomes of bacterial co-detections by blood culture among children and adults hospitalized with laboratory-confirmed influenza, Influenza Hospitalization Surveillance Network, 2022-2024

实验室确诊流感住院儿童和成人中,通过血培养检测到的细菌共感染患病率及结局,流感住院监测网络,2022-2024

2026-05-200
PRE
Effects of age and birth cohort on influenza A virus subtype-specific hospitalization rates, United States 2010-2025

年龄和出生队列对美国2010-2025年甲型流感病毒亚型特异性住院率的影响

2026-01-010
PRE
Chronic Conditions as Risk Factors for COVID-19–Associated Hospitalization Among Adults, 2020–2023

2020-2023年成人慢性疾病作为COVID-19相关住院的风险因素

2025-12-190
OAAI
Severity of Clinical Presentation and Outcomes in Hospitalized Adult People With Influenza by Type and Subtype, United States-2017-2020

临床表现的严重程度及住院成人流感患者的结局:按类型和亚型分类,美国-2017-2020

2025-10-010
PRE
Ongoing Symptoms After Acute SARS-CoV-2 or Influenza Infection in a Case-Ascertained Household Transmission Study: 7 US Sites, 2021-2023
2025-02-010
PRE
Vaccine effectiveness against influenza-associated hospitalizations in adults with liver disease, 2015-2020: US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN)

2015-2020: 美国成人住院流感疫苗有效性网络 (HAIVEN)

2025-01-280
OAAI
Effectiveness of mRNA COVID-19 Vaccines and Hybrid Immunity in Preventing SARS-CoV-2 Infection and Symptomatic COVID-19 Among Adults in the United States

mRNA新型冠状病毒肺炎疫苗和杂交免疫预防美国成人SARS-CoV-2感染和症状新型冠状病毒肺炎的有效性

2025-01-080
PRE
Asymptomatic and Mildly Symptomatic Influenza Virus Infections by Season: Case-Ascertained Household Transmission Studies, United States, 2017-2023

按季节进行的无症状和轻度症状的流感病毒感染: 病例确定的家庭传播研究,美国,2017-2023

2024-11-271
OA
Effectiveness of Original Monovalent and Bivalent COVID-19 Vaccines Against COVID-19-Associated Hospitalization and Severe In-Hospital Outcomes Among Adults in the United States, September 2022-August 2023

2022年9月-2023年8月,原始单价和二价新型冠状病毒肺炎疫苗对美国成人COVID-19-Associated住院和严重住院结局的有效性

2024-11-040
OA
Trends in COVID-19-Attributable Hospitalizations Among Adults With Laboratory-Confirmed SARS-CoV-2-COVID-NET, June 2020 to September 2023
2024-11-040
OA
The Burden of All-Cause Mortality Following Influenza-Associated Hospitalizations: Influenza Hospitalization Surveillance Network, 2010-2019
2024-11-040
OA
Extrapolating Sentinel Surveillance Information to Estimate National COVID Hospital Admission Rates: A Bayesian Modeling Approach
2024-10-230
OA